Why Genentech will say 'yes' to Roche
CNNMoney.com - 3 hours ago

As drugs from the first wave of biotech approvals two decades ago are approaching patent expiration, patients, doctors and insurers are demanding ...
Leave a Reply

You must be logged in to post a comment. Login »